Spiden Announces Breakthrough in Non-Invasive Glucose Monitoring, Adds Key Executive Hires and Secures $15m in Additional Funding BioTech January 6, 2024 Spiden, a pioneer in non-invasive biomarker monitoring technology, is thrilled to announce a significant scientific milestone, key additions to its…
